Adenylyl cyclase supersensitivity in opioid-withdrawn NG108-15 hybrid cells requires G(s) but is not mediated the G(s)α subunit

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 855-862

  Ammer, Hermann ^a   Schulz, Rüdiger ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; ADENYLATE CYCLASE; CHOLERA TOXIN; FORSKOLIN; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MORPHINE; NALOXONE; OPIATE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG WITHDRAWAL; ENZYME ACTIVITY; GLIOMA CELL; HUMAN; HUMAN CELL; HYBRID CELL; NEUROBLASTOMA CELL; OPIATE ADDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPERSENSITIVITY;

ADENYLATE CYCLASE; ALPROSTADIL; CELL LINE; FORSKOLIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; HYBRID CELLS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RECEPTORS, OPIOID, DELTA; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032424646     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. s-adenylate cyclase interactions. FASEB J 5:2300-2303.
2. s is enhanced in neuroblastoma x glioma (NG108-15) hybrid cells chronically exposed to an opioid. Mol Pharmacol 43:556-563.
3. 1 receptor system in neuroblastoma x glioma (NG108-15) hybrid cells. J Neurochem 64:2449-2457.
4. Ammer H and Schulz R (1997) Chronic morphine treatment increases stimulatory beta-2 adrenoceptor signaling in A431 cells stably expressing the mu opioid receptor. J Pharmacol Exp Ther 280:512-520.
5. Avidor-Reiss T, Zippel R, Levy R, Saya R, Ezra V, Barg J, Matus-Leibovich N and Vogel Z (1995a) Kappa-opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments. FEBS Lett 361:70-74.
6. Avidor-Reiss T, Bayewitch M, Levy R, Matus-Leibovich N, Nevo I and Vogel Z (1995b) Adenylylcyclase supersensitization in μ-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J Biol Chem 270: 29732-29738.
7. Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T and Vogel Z (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. J Biol Chem 271:21309-21315.
8. Avidor-Reiss T, Nevo I, Saya D, Bayewitch M and Vogel Z (1997) Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem 272:5040-5047.
9. Cassel P and Selinger Z (1977) Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc Natl Acad Sci USA 74:3307-3311.
10. Chen Y, Mestek A, Liu J, Hurley JA and Yu L (1993) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol Pharmacol 44:8-12.
11. Childers SR (1991) Opioid Receptor-Coupled Second Messenger Systems. Life Sci 48:1991-2003.
12. Childers SR and LaRiviere G (1984) Modification of guanine nucleotide-regulatory components in brain membranes - II. relationship of guanosine 5′-triphosphate effects on opiate receptor binding and coupling receptors with adenylate cyclase. J Neurosci 4:2764-2771.
13. Choi EJ, Wong ST, Hinds TR and Storm DR (1992) Calcium and muscarinic agonist stimulation of type-I adenylyl cyclase in whole cells. J Biol Chem 267:12440-12442.
14. Collier HOJ (1984) Cellular aspects of opioid tolerance and dependence, in Opioids Past, Present and Future (Hughes J, Collier HOJ, Rance MJ and Tyres MB eds) pp 109-125, Taylor & Frances Ltd., London.
15. DeBlasi A, O'Reilly K and Motulsky HJ (1989) Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol Sci 10:227-229.
16. i-protein βγ subunits. Nature 256:159-161.
17. 32P]ADP-ribosylation of proteins. Methods Enzymol 195:267-280.
18. Gilman AG (1987) G Proteins: transducers of receptor-generated signals. Annu Rev Biochem 56:615-649.
19. Hamprecht B, Glaser T, Reiser G, Bayer E and Probst F (1985) Culture and characteristics of hormone-responsive neuroblastoma x glioma hybrid cells. Methods Enzymol 109:316-341.
20. Kawabe J, Iwami G, Ebina T, Ohno S, Katada T, Ueda Y, Homcy CJ and Ishikawa Y (1994) Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J Biol Chem 269:16554-16558.
21. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ and von Zastrow M (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271:19021-19024.
22. 2-adrenoceptor-expressing NG 108-15 cells. Biochem J 308:275-281.
23. Law P-Y, Hom DS and Loh HH (1984) Down-regulation of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells. J Biol Chem 259:4096-4104.
24. Law P-Y, McGinn TM, Wick MJ, Erikson LJ, Evans C and Loh HH (1994) Analysis of delta-opioid receptor activities stably expressed in CHO cell lines: function of receptor density? J Pharmacol Exp Ther 271:1686-1694.
25. 2-adrenergic receptor agonists in NG108-15 cells. FASEB J 2:52-55.
26. 2-adrenoceptor. Biochem J 318: 1033-1039.
27. i2. Biochem J 367:391-398.
28. Nestler EJ, Hope BT and Widnell KL (1993) Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11:995-1006.
29. s in heterologous desensitization: a role for cAMP dependent phosphorylation. Endocrinology 131:2774-2783.
30. Reisine T and Bell GI (1993) Molecular biology of opioid receptors. Trends Neurosci 16:506-510.
31. Sharma SK, Klee WA and Nirenberg M (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA 72:3092-3096.
32. Sunahara RK, Dessauer CW and Gilman AG (1996) Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36:461-480.
33. Sutkowski EM, Robbins JD, Tang W-J and Seamon KB (1996) Irreversible inhibition of forskolin interactions with type I adenylyl cyclase by a 6-isothiocyanate derivative of forskolin. Mol Pharmacol 50:299-305.
34. Tang WJ and Gilman AG (1991) Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science 254:1500-1503.
35. Taussig R, Tang W-J, Hepler JR and Gilman AG (1994) Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. J Biol Chem 269:6093-6100.
36. Thomas JM and Hoffman BB (1987) Adenylate cyclase supersensitivity: a general means of cellular adaptation to inhibitory agonists? Trends Pharmacol Sci 8:308-311.
37. Thomas JM and Hoffman BB (1996) Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of βγ subunits in transducing enhanced activity of the type VI isoform. Mol Pharmacol 49:907-914.
38. Vachon L, Costa T and Herz A (1987) GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells. Mol Pharmacol 31:159-168.
39. i2 inhibit cyclic AMP accumulation. Nature 351:63-65.
40. Yu VC, Eiger S, Duan D-S, Lameh J and Sadée W (1990) Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells. J Neurochem 55:1390-1396.